Allopurinol improves postischemic skeletal muscle performance and endurance but not high-energy phosphate levels.
D000255:Adenosine Triphosphate / Q000378:metabolism*; D000493:Allopurinol / Q000494:pharmacology*; D000818:Animals; D004734:Energy Metabolism / Q000187:drug effects / Q000502:physiology*; D007511:Ischemia / Q000378:metabolism / Q000503:physiopathology*; D008297:Male; D018763:Muscle Fatigue / Q000187:drug effects / Q000502:physiology*; D018482:Muscle, Skeletal / Q000098:blood supply* / Q000187:drug effects* / Q000503:physiopathology; D010725:Phosphocreatine / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D012016:Reference Values; D015427:Reperfusion Injury / Q000517:prevention & control*
D010725:Phosphocreatine; D000493:Allopurinol; D000255:Adenosine Triphosphate